Curated News
By: NewsRamp Editorial Staff
November 05, 2025
NextPlat's PharmcoRx Secures Multi-State Deal with DevotedDOc
TLDR
- NextPlat's PharmcoRx gains exclusive prescription fulfillment contract with DevotedDOc, expanding its healthcare services footprint and creating new revenue streams in multiple states.
- PharmcoRx will begin serving patients in Florida and Georgia in November through this multi-state contract, with planned expansion across all licensed territories nationally.
- This partnership improves access to rapid, affordable, and quality medical care for patients nationwide, particularly for opioid treatment and weight loss therapies.
- NextPlat's subsidiary now provides prescription services for innovative treatments including Medication-Assisted Therapy and compounded alternatives to GLP-1 weight loss drugs.
Impact - Why it Matters
This partnership significantly expands access to specialized healthcare services, particularly for patients seeking virtual urgent care, opioid use disorder treatment, and compounded alternatives to GLP-1 weight loss therapies. As telehealth continues to transform healthcare delivery, this collaboration addresses critical gaps in medication access and specialized treatment options. For patients in underserved areas or those requiring specialized care like Medication-Assisted Treatment, this expansion could mean faster access to life-changing therapies. The national rollout plan indicates a broader trend toward decentralized healthcare delivery, potentially reducing barriers to treatment for chronic conditions and substance use disorders across multiple states.
Summary
NextPlat Corp (NASDAQ: NXPL, NXPLW), a global provider of healthcare and technology solutions, has announced a significant expansion through its PharmcoRx subsidiary. The company has secured an exclusive multi-state prescription fulfillment services contract from DevotedDOc, a virtual medical group specializing in urgent care, Medication-Assisted Treatment for opioid use disorder, and compounded alternatives to GLP-1 therapies for weight loss and hormone replacement therapy. This partnership represents a strategic move for NextPlat as it continues to build its healthcare services portfolio, with PharmcoRx set to begin serving patients in Florida and Georgia in November, followed by national expansion across its licensed territories.
The collaboration underscores NextPlat's commitment to improving healthcare accessibility nationwide, as emphasized by Vice President of Healthcare Operations Birute Norkute, who highlighted the company's focus on providing rapid, affordable, and quality medical care. NextPlat operates as a global consumer products and services company offering healthcare and technology solutions through e-commerce and retail channels worldwide. Through its various subsidiaries, including Progressive Care, the company provides pharmacy and healthcare data management services in the United States, along with e-commerce communications solutions featuring voice, data, tracking, and IoT products globally. This news was distributed through BioMedWire, which is part of the Dynamic Brand Portfolio within the Investor Brand Network (IBN), a specialized communications platform focused on biotechnology and life sciences sectors.
Source Statement
This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, NextPlat's PharmcoRx Secures Multi-State Deal with DevotedDOc
